# Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

> **NCT05206578** · PHASE3 · UNKNOWN · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 264 (estimated)

## Conditions studied

- Primary Hypercholesterolemia

## Interventions

- **DRUG:** AGT2, AGZ
- **DRUG:** AGT2
- **DRUG:** AGT4, AGZ
- **DRUG:** AGT4

## Key facts

- **NCT ID:** NCT05206578
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-08
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-09-08
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2022-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05206578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05206578, "Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05206578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*